Therapeutic Advances in Endocrinology and Metabolism·10 SepAssociation between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacologyStudy in peoplePopulationsPaper
bioRxiv·20 AugThe HES1-SOD1 Antagonism Shapes Senescence Heterogeneity and Impacts Metastatic Relapse of Circulating Tumor CellsPreprint: experiments in cellsMechanismsPaper